Illumina to pay $30M to Standard BioTools for licensing and royalty obligations.
Illumina Inc. will pay Standard BioTools $30,041,683.63 to terminate ongoing Royalty Agreements and a License Agreement following their 2025 merger.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day